EP Patent

EP0667346A2 — Azole antifungal agents, process for the preparation there of and intermediates

Assigned to Eisai Co Ltd · Expires 1995-08-16 · 31y expired

What this patent protects

A compound represented by the general formula: wherein R 1 and R 2 denote a halogen atom or hydrogen atom; R 3 means a hydrogen atom or lower alkyl group; ℓ , r and m stand for 0 or 1; A is N or CH; W denotes an aromatic ring or a condensed ring thereof; X means another a…

USPTO Abstract

A compound represented by the general formula: wherein R 1 and R 2 denote a halogen atom or hydrogen atom; R 3 means a hydrogen atom or lower alkyl group; ℓ , r and m stand for 0 or 1; A is N or CH; W denotes an aromatic ring or a condensed ring thereof; X means another aromatic ring, an alkanediyl group, an alkenediyl group, or an alkynediyl group; Y stand for -S-, etc.; Z denotes a hydrogen atom, etc., or a salt thereof, and intermediates thereof or a salt thereof as well as processes for the preparation thereof, and pharmacetical composition suitable for use as an antifungal agent.

Drugs covered by this patent

Patent Metadata

Patent number
EP0667346A2
Jurisdiction
EP
Classification
Expires
1995-08-16
Drug substance claim
No
Drug product claim
No
Assignee
Eisai Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.